Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.

OBJECTIVE To compare the relationship of surrogate markers of asthma control to subsequent asthma exacerbations. STUDY DESIGN Retrospective cohort. METHODS Administrative data were used to identify patients who met the Healthcare Effectiveness Data and Information Set (HEDIS) criteria for persistent asthma in 2006 and 2007. The following potential surrogate markers of asthma control assessed in 2007 were compared for their ability to predict asthma exacerbations in 2008 (defined as oral corticosteroid dispensing or an asthma hospitalization or emergency department visit): dispensing of any controller, unweighted medication ratio (the ratio of controller to total medication), weighted medication ratio, and the number of short-acting beta-agonist (SABA) canisters dispensed. Weighted medication ratios were weighted for controller potency and for doses per container. RESULTS Meeting the HEDIS criteria for persistent asthma were 8634 patients (60.5% female) aged 18 to 56 years (mean age, 42.7 years), of whom 6.5% experienced emergency hospital care and 27.3% received oral corticosteroids in 2008. The largest effect size for predicting reduced emergency hospital care was for the number of SABA canisters dispensed (odds ratio [OR], 0.49; 95% confidence interval [CI], 0.40-0.60), followed by the unweighted medication ratio (OR, 0.54; 95% CI, 0.40-0.72), and then the weighted medication ratio (OR, 0.57; 95% CI, 0.45-0.73). Dispensing of any controller was associated with a nonsignificant increased risk of emergency hospital care (OR, 1.41; 95% CI, 0.95-2.09). CONCLUSIONS The number of SABA canisters dispensed is most strongly related to improved asthma outcomes, followed by the unweighted medication ratio; dispensing of any controller is least related. Health plans can use the number of SABA canisters dispensed and the unweighted medication ratio for asthma population management or for provider quality-of-care assessment to reduce asthma exacerbations, which exact a high economic and humanistic cost.

[1]  P. Yong,et al.  Process quality measures and asthma exacerbations in the medicaid population. , 2009, The Journal of allergy and clinical immunology.

[2]  M. Bharmal,et al.  Incremental Direct Expenditure of Treating Asthma in the United States , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[3]  Toshiyuki Yamagata,et al.  The Strategy for Predicting Future Exacerbation of Asthma Using a Combination of the Asthma Control Test and Lung Function Test , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[4]  S. Peters,et al.  Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. , 2007, The Journal of allergy and clinical immunology.

[5]  M. Kosinski,et al.  Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. , 2007, The Journal of allergy and clinical immunology.

[6]  Guillermo Mendoza,et al.  The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. , 2006, Chest.

[7]  E. Gelfand,et al.  A focus on the asthma HEDIS measure and its implications for clinical practice. , 2006, Managed care interface.

[8]  M. Schatz,et al.  How well do the HEDIS asthma inclusion criteria identify persistent asthma? , 2005, The American journal of managed care.

[9]  Guillermo Mendoza,et al.  Asthma quality-of-care markers using administrative data. , 2005, Chest.

[10]  M. Blaiss,et al.  The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  R. Adams,et al.  Evaluation of Asthma Prescription Measures and Health System Performance Based on Emergency Department Utilization , 2004, Medical care.

[12]  E. Yelin,et al.  A comprehensive study of the direct and indirect costs of adult asthma. , 2003, The Journal of allergy and clinical immunology.